Seed is raising the bar for bacteria with science-based probiotics.Visit
“For us, the communication of science is as important as doing good science. But you have to meet people where they are. We understand that science can feel intimidating and complex, so we use design, art, poetry, and pop culture as trojan horses. We think about it as building doors people can walk through. And we’re just getting started.”
Founded in 2017 by Ara Katz and Raja Dhir, Seed is working to improve human and planetary health through the microbiome: the community of 38 trillion microorganisms living inside our bodies.
The company uses clinical research, proprietary technology, and innovations in biofermentation, stabilization, and testing to develop consumer health products for the “whole-body biome.” Combining probiotics and prebiotics, Seed’s Daily Synbiotic supplement goes beyond the gut, offering multi-system benefits to promote a holistic approach to health.
Seed in the news
11/02/22 on Yahoo!
New Clinical Trial Finds Seed's Pediatric Synbiotic PDS-08™ Impacts Gut Microbiome and Bowel Movements in Children
08/04/22 on Forbes
To Support Mental Wellbeing, Seed Health Launches a Gut-Brain Development Program in Partnership With Axial Therapeutics
04/12/22 on PR Newswire
Seed Expands into Children's Health with Launch of Its First Clinically Studied Pediatric Synbiotic
01/04/22 on Fox8
After A Year Of Testing, Seed Has Become My Go-To Probiotic. Here’s Why I Love It
04/21/21 on WWD
Seed Health Secures $40 Million in Series A Funding
02/12/21 on LA Business Journal
Seed Health Acquires AI Company
04/10/20 on DuJour
Ara Katz Suggests You Listen to Your Gut
02/24/20 on WSJ
Startups Wrap Brand Identity With Sustainable Packaging